ARTICOLI CON IMPACT FACTORGuarino MP,
Carotti S, Sarzano M, Alloni R, Vanni M, Grosso M, Sironi G, Maffettone PL, Cicala
M.
Short-term ursodeoxycholic acid treatment improves gallbladder bile
turnover in gallstone patients: a randomized trial.
Neurogastroenterol
Motil. 2005 Oct;17(5):680-6. IF 2.549
Vespasiani Gentilucci U, Caviglia
R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M.
Infliximab reverses growth hormone resistance associated with inflammatory
bowel disease.
Aliment Pharmacol Ther. 2005 May 1;21(9):1063-71. Erratum
in: Aliment Pharmacol Ther. 2005 Jun 1;21(11):1398. IF 3.981
Caviglia
R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MP, Carotti S,
Habib FI, Rabitti C, Cicala M.
Dilated intercellular spaces of esophageal
epithelium in nonerosive reflux disease patients with physiological esophageal
acid exposure.
Am J Gastroenterol. 2005 Mar;100(3):543-8. IF 4.716
Cicala
M, Gabbrielli A, Emerenziani S, Guarino MP, Ribolsi M, Caviglia R, Costamagna
G.
Effect of endoscopic augmentation of the lower oesophageal sphincter
(Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics
of acid reflux.
Gut. 2005 Feb;54(2):183-6. IF 6.601
ATTI
DI CONGRESSO
Caviglia R, Carotti S, Vespasiani Gentilucci U, Picardi A,
Ribolsi M, Afeltra A, Cicala M.
Anti-tumor necrosis factor alpha reverts
growth hormone resistance associated with inflammatory bowel disease.
XI
National Congress of Digestive Diseases. Genova, 12-16 marzo 2005.
Dig Liver
Dis 2005; 37(S1): S140.